CRISPR-on-Chip for Point-of-Care Diagnostics

Area of Science:

• Biotechnology and Biomedical Engineering
• Molecular Diagnostics
• Nanotechnology

Background:

• CRISPR-based diagnostic platforms offer high sensitivity and specificity for detecting pathogens and diseases.
• Point-of-care (PoC) applications are increasingly adopting these platforms due to their practical advantages.
• CRISPR-Cas technology is widely used, but its integration with microfluidics for PoC diagnostics requires further understanding.

Purpose of the Study:

• To review recent advancements in CRISPR-on-chip diagnostic technologies.
• To highlight the potential applications of CRISPR-on-chip in infectious diseases, biosensors, and personalized medicine.
• To discuss challenges and future perspectives for developing ideal diagnostic solutions.

Main Methods:

• Integration of CRISPR-Cas systems with microfluidic devices to create CRISPR-on-chip platforms.
• Review of existing literature on CRISPR-on-chip technology and its applications.
• Analysis of the advantages, challenges, and future directions of CRISPR-on-chip diagnostics.

Main Results:

• CRISPR-on-chip platforms enable scalable, portable, real-time, and precise biomolecule detection.
• These platforms offer single-molecule sensitivity, multiplex detection capabilities, and enhanced diagnostic accuracy.
• CRISPR-on-chip technology reduces processing times and the need for extensive laboratory infrastructure.

Conclusions:

• CRISPR-on-chip technology represents a significant advancement in diagnostics, particularly for PoC applications.
• The technology holds great promise for rapid detection of infectious diseases and enabling personalized medicine.
• Addressing integration challenges is crucial for realizing the full potential of CRISPR-on-chip for ideal diagnostic solutions.